Agilon Health (AGL) Earnings Analysis
Agilon Health (AGL) has no confirmed upcoming earnings date. Last quarter (2026-02-25) it missed with EPS -11.5 USD vs -6.75 USD est (-70.4%). It has beaten estimates in 1/4 recent quarters (25%). Trailing P/E -5.28.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does AGL next report earnings?
No confirmed upcoming earnings date is currently scheduled for AGL. This page updates as the calendar is published.
AGL earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-25 | -11.5 USD | -6.75 USD | -70.4% | Miss |
| 2025-08-04 | -0.25 USD | -0.11 USD | -127.3% | Miss |
| 2024-11-07 | -0.29 USD | -0.1 USD | -190% | Miss |
| 2024-08-05 | -1.75 USD | -1.75 USD | 0% | Beat |
Beat rate: 1/4 (25%) over reported quarters with consensus data.
AGL valuation and analyst view
| Trailing P/E | -5.28 |
|---|---|
| Trailing EPS | -22.50057 USD |
| Price / book | 10.97 |
| Dividend yield | 0.00% |
| Market cap | 1.97B |
| Analyst consensus | Hold (8 buy / 15 hold / 2 sell) |
| Avg price target | 78.2 USD |
Related research pages
Frequently asked questions
When is Agilon Health (AGL)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for AGL. This page updates as the calendar is published.
Did AGL beat earnings last quarter?
In its 2026-02-25 report, AGL posted EPS of -11.5 USD versus a -6.75 USD estimate — a miss of 70.4%.
What is AGL's earnings track record?
Over the last 4 reported quarters with consensus data, AGL beat estimates 1 times (25%).
What is AGL's current P/E ratio and EPS?
AGL trades at a trailing P/E of -5.28 on trailing EPS of -22.500572323633953 USD.
What do analysts rate AGL?
Analyst consensus is "Hold" across 25 ratings (0 strong buy, 8 buy, 15 hold, 2 sell, 0 strong sell). Average 12-month price target: 78.2 USD.